Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: A study of the EULAR Scleroderma Trial and Research group

Arthritis Research and Therapy

Volumn 14, Issue 1, 2012, Pages

  Foocharoen, Chingching ^a   Tyndall, Alan ^a   Hachulla, Eric ^b   Rosato, Edoardo ^c   Allanore, Yannick ^d   Farge Bancel, Dominique ^e   Caramaschi, Paola ^f   Airó, Paolo ^g   Starovojtova, M Nikolaevna ^h   Pereira da Silva, José A ⁱ   Stamenkovic, Bojana ^j   Riemekasten, Gabriela ^k   Rednic, Simona ^l   Sibilia, Jean ^m   Wiland, Piotr ⁿ   Tarner, Ingo ^o   Smith, Vanessa ^p   Onken, Anna T ^q   Abdel Atty Mohamed, Walid A ^r   Distler, Oliver ^s   Morović Vergles, Jadranka ^t   Himsel, Andrea ^u   de la Peña Lefebvre, Paloma G ^v   Hügle, Thomas ^a   Walker, Ulrich A ^a   more..

^a UNIVERSITY OF BASEL   (Switzerland)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Institut Cochin   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f UNIVERSITY OF VERONA   (Italy)

^g SPEDALI CIVILI   (Italy)

^h V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

ⁱ CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^j Institute for Prevention   (Serbia)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^m UNIVERSITY HOSPITAL OF STRASBOURG   (France)

ⁿ WROCLAW MEDICAL UNIVERSITY   (Poland)

^o JUSTUS LIEBIG UNIVERSITY   (Germany)

^p GHENT UNIVERSITY   (Belgium)

^q TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^r ALEXANDRIA UNIVERSITY   (Egypt)

^s UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^t University of Zagreb   (Croatia)

^u GOETHE UNIVERSITY   (Germany)

^v Hospital Madrid Norte   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1; SILDENAFIL; TADALAFIL; VARDENAFIL; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE; VASODILATOR AGENT;

ACROCYANOSIS; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DRUG EFFICACY; ERECTILE DYSFUNCTION; HUMAN; INFORMATION PROCESSING; INTERNATIONAL INDEX OF ERECTILE FUNCTION; KIDNEY DISEASE; LUNG DISEASE; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; MUSCLE DISEASE; PENIS PROSTHESIS; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SKIN DISEASE; SYSTEMIC SCLEROSIS; CLINICAL TRIAL; FACTUAL DATABASE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; STATISTICS; TREATMENT OUTCOME;

ADULT; DATABASES, FACTUAL; ERECTILE DYSFUNCTION; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MUSCULAR DISEASES; PIPERAZINES; PROSPECTIVE STUDIES; PURINES; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84857129610     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3748     Document Type: Article

References (25)

1. Herrick A. Diagnosis and management of scleroderma peripheral vascular disease. Rheum Dis Clin North Am 2008, 34:89-114. 10.1016/j.rdc.2007.11.006, 18329535.
2. Lally EV, Jimenez SA. Impotence in progressively systemic sclerosis. Ann Intern Med 1981, 95:150-153.
3. Nowlin NS, Brick JE, Weaver DJ, Wilson DA, Judd HL, Lu JK, Carlson HE. Impotence in scleroderma. Ann Intern Med 1986, 104:794-798.
4. Hong P, Pope JE, Ouimet JM, Rullan E, Seibold JR. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis. J Rheumatol 2004, 31:508-513.
5. Lally EV, Jimenez SA. Erectile failure in systemic sclerosis. N Engl J Med 1990, 322:1398-1399.
6. Aversa A, Proietti M, Bruzziches R, Salsano F, Spera G. The penile vasculature in systemic sclerosis: a duplex ultrasound study. J Sex Med 2006, 3:554-558. 10.1111/j.1743-6109.2005.00169.x, 16681482.
7. Nehra A, Hall SJ, Basile G, Bertero EB, Moreland R, Toselli P, de las MA, Goldstein I. Systemic sclerosis and impotence: a clinicopathological correlation. J Urol 1995, 153:1140-1146. 10.1016/S0022-5347(01)67533-5, 7869483.
8. Walker UA, Tyndall A, Ruszat R. Erectile dysfunction in systemic sclerosis. Ann Rheum Dis 2009, 68:1083-1085. 10.1136/ard.2008.096909, 19525406.
9. Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, Muller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007, 66:754-763. 10.1136/ard.2006.062901, 1954657, 17234652.
10. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999, 11:319-326.
11. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005, 47:80-85. 10.1016/j.eururo.2004.08.017, 15582253.
12. McVary KT. Clinical practice. Erectile dysfunction. N Engl J Med 2007, 357:2472-2481. 10.1056/NEJMcp067261, 18077811.
13. Valentini G, Bencivelli W, Bombardieri S, D'Angelo S, Della RA, Silman AJ, Black CM, Czirjak L, Nielsen H, Vlachoyiannopoulos PG. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003, 62:901-903. 10.1136/ard.62.9.901, 1754649, 12922968.
14. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994, 151:54-61.
15. Junuzovic D, Hasanbegovic M, Masic I. Risk factors for erectile dysfunction in patients with newly diagnosed diabetes mellitus. Med Arh 2010, 64:345-347.
16. Yang G, Pan C, Lu J. Prevalence of erectile dysfunction among Chinese men with type 2 diabetes mellitus. Int J Impot Res 2010, 22:310-317. 10.1038/ijir.2010.21, 20811390.
17. Bener A, Al-Hamaq AO, Kamran S, Al-Ansari A. Prevalence of erectile dysfunction in male stroke patients, and associated co-morbidities and risk factors. Int Urol Nephrol 2008, 40:701-708. 10.1007/s11255-008-9334-y, 18246439.
18. Erden I, Ozhan H, Ordu S, Yalcin S, Caglar O, Kayikci A. The effect of non-dipper pattern of hypertension on erectile dysfunction. Blood Press 2010, 19:249-253. 10.3109/08037050903576734, 20070248.
19. Heruti RJ, Sharabi Y, Arbel Y, Shochat T, Swartzon M, Brenner G, Justo D. The prevalence of erectile dysfunction among hypertensive and prehypertensive men aged 25-40 years. J Sex Med 2007, 4:596-601. 10.1111/j.1743-6109.2007.00489.x, 17498098.
20. Aranda P, Ruilope LM, Calvo C, Luque M, Coca A, Gil de MA. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study. Am J Hypertens 2004, 17:139-145. 10.1016/j.amjhyper.2003.09.006, 14751656.
21. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005, 294:2996-3002. 10.1001/jama.294.23.2996, 16414947.
22. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010, 57:804-814. 10.1016/j.eururo.2010.02.020, 20189712.
23. Ostojic P, Damjanov N. The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis. Clin Rheumatol 2007, 26:1671-1674. 10.1007/s10067-007-0567-4, 17294050.
24. Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 2007, 19:200-207. 10.1038/sj.ijir.3901513, 16943794.
25. Proietti M, Aversa A, Letizia C, Rossi C, Menghi G, Bruzziches R, Merla A, Spera G, Salsano F. Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels. J Rheumatol 2007, 34:1712-1717.